Goldman Sachs Q1 2026: Record Trading Revenue Can’t Calm a Wary Market
Goldman Sachs beat Q1 2026 estimates with record $5.33B equity trading revenue and 19% profit growth — but the stock still slid. Here’s why Wall Street is cautious.
Goldman Sachs beat Q1 2026 estimates with record $5.33B equity trading revenue and 19% profit growth — but the stock still slid. Here’s why Wall Street is cautious.
JPMorgan profits surged 15% to $16.5B in Q1 2026, leading a blockbuster quarter for Wall Street banks. But CEO Dimon is warning of an increasingly complex risk environment.
Netflix reports Q1 2026 earnings on April 16. Here’s what Wall Street is watching: ad-tier growth, engagement metrics, margins, and macro risks.
Apple, Meta, and Alphabet report Q1 2026 earnings this month. Here’s what Wall Street expects and why AI returns are the central question.
U.S. existing home sales fell 3.6% in March—far worse than the 0.7% consensus estimate. What the miss means for homebuilder stocks, REITs, and mortgage markets.
From protein folding to clinical trials, AI is transforming drug discovery. Novo Nordisk’s OpenAI deal is the latest signal for pharma investors.
The Trump administration’s 100% pharmaceutical tariff threat is testing drug stock valuations, global supply chains, and corporate bond markets.
OpenAI’s private market valuation has ballooned to $852 billion, but some of its own backers are questioning the math as the company shifts strategic focus.
Amazon is in advanced talks to acquire Globalstar, a move that could reshape the satellite internet race against SpaceX Starlink and trigger a new wave of space sector M&A.
ASML reports Q1 2026 earnings this week. As the sole maker of EUV machines, its order book is the best indicator of where the AI chip supercycle is headed.